Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of serum vitamin D levels in vitiligo.
Karagün E, Ergin C, Baysak S, Erden G, Aktaş H, Ekiz Ö. Karagün E, et al. Among authors: baysak s. Postepy Dermatol Alergol. 2016 Aug;33(4):300-2. doi: 10.5114/pdia.2016.59507. Epub 2016 Aug 16. Postepy Dermatol Alergol. 2016. PMID: 27605903 Free PMC article.
The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey.
Kartal SP, Çelik G, Yılmaz O, Öksüm Solak E, Demirbağ Gül B, Üstünbaş TK, Gönülal M, Baysak S, Yüksel Eİ, Ünlü B, Güven M, Bozdağ A, Çınar G, Kartal S, Borlu M, Özden MG, Engin B, Serdaroğlu S, Balcı DD, Doğan B, Çiçek D, Yazıcı AC, Aytekin S, Şendur N, Sarıcaoglu H, Kaçar NG, Doğramacı AC, Dönmez L, Alpsoy E. Kartal SP, et al. Among authors: baysak s. J Dermatolog Treat. 2022 Jun;33(4):2137-2144. doi: 10.1080/09546634.2021.1927947. Epub 2021 May 24. J Dermatolog Treat. 2022. PMID: 34030547
Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity.
Özkur E, Karadağ AS, Üstüner P, Aksoy B, Eşme P, Çalışkan E, Akoğlu G, Kalkan G, Demirseren DD, Polat M, Ozden MG, Kılınç F, Yalçınkaya İyidal A, Kıvanç Altunay İ, Türkmen M, Uğurer E, Baysak S, Fettahlıoğlu Karaman B, Mammadlı K, Baykal Selçuk L, Türkoğlu Z, Atcı T, Didar Balcı D, Adışen E, Temel B, Aktan Ş, Kaçar N, Gündüz K, Türel Ermertcan A, Özdemir M, Ünal Çakıter A, Çölgeçen E, Uçmak D, Kelekçi H, Ataseven A, Durmaz K, Kaya Özden H, Engin B, Yazıcı S, Alpsoy E. Özkur E, et al. Among authors: baysak s. Clin Exp Dermatol. 2021 Apr;46(3):532-540. doi: 10.1111/ced.14478. Epub 2021 Jan 2. Clin Exp Dermatol. 2021. PMID: 33030217
Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study.
Oguz Topal I, Baysak S, Altunay İK, Kara Polat A, Arıkan EE, Özkur E, Aytekin S, Dogan B, Özkök Akbulut T, Topaloğlu Demir F, Karadağ AS. Oguz Topal I, et al. Among authors: baysak s. An Bras Dermatol. 2022 Sep-Oct;97(5):566-574. doi: 10.1016/j.abd.2021.11.002. Epub 2022 Jul 15. An Bras Dermatol. 2022. PMID: 35843765 Free PMC article.